HIV/AIDS Clinical Trials Networks
The NIAID HIV/AIDS Clinical Trials Networks have been designed to address one or more of NIAID’s six high priority areas of research:
-
Vaccine Research and Development (HVTN)
-
Translational Research/Drug Development (ACTG, IMPAACT)
-
Optimization of Clinical Management, Including Co-Morbidities (ACTG, IMPAACT, INSIGHT)
-
Microbicides (MTN)
-
Prevention of Mother-to-Child Transmission of HIV (IMPAACT)
-
Prevention of HIV Infection (HVTN, HPTN)
Non-Government Links
- Principal Investigator: Sten Vermund, M.D., Ph.D.
- Primary research focus: evaluating non-vaccine HIV prevention strategies
- Principal Investigator: Lawrence Corey, M.D.
- Primary research focus: evaluating preventive HIV vaccines
- Principal Investigator: Jay Brooks Jackson, M.D., M.B.A.
- Primary research focus: preventing mother to child transmission of HIV, optimizing clinical management of HIV, including co-morbidities and other HIV-related conditions in children, adolescents and pregnant women
- Principal Investigator: James D. Neaton, Ph.D.
- Primary research focus: optimizing clinical management of HIV/AIDS, including co-infections and other HIV-related conditions
- Principal Investigator: Sharon Hillier, Ph.D.
- Primary research focus: evaluating microbicides for HIV prevention
back to top